Skip to main content

Intellectual Property Disputes

Intellectual Property assets are frequently seen as being amongst the most valuable assets of a business and as such the volume of disputes that have arisen in the field has grown substantially and the applicable area of law is frequently changing and often complex.

One of the biggest in the UK, our team is a highly respected provider of Intellectual Property Dispute Resolution services, acting for some of the largest companies in the world as well as for small and medium businesses. Many of our lawyers are ranked as leaders in the field and have experience of all relevant tribunals from the Intellectual Property Office through to the European Court of Justice.

Whilst our objective is often to resolve disputes with the minimum of fuss and costs, we also have a track record of acting in and winning the most complex IP disputes and creating substantial value for our clients.  Many of the disputes that we work on have multi-jurisdictional aspects to them.

Our areas of expertise include:

  • copyright
  • database rights
  • designs
  • patents
  • trade marks
  • trade secrets
  • unfair competition

 

Related items

Brands and IP newsnotes - issue 6

13 October 2017

Welcome to the 6th edition of our Brands & IP newsnotes put together to bring you the latest, and most interesting legal developments affecting intellectual property law. In this issue we cover; battlegrounds on Amazon listings, whether prestigious brands can prevent their resellers from selling online, the EU's position paper on IP rights, an quick guide on rights for designs, and trade mark infringements.

A guide to the litigation process

15 August 2017

If you are involved in a dispute you need to know: what options there are for resolving the dispute; what litigation involves; the steps from the start of proceedings to trial; what parties to proceedings have to do; the fundamentals of court procedure; how to use legal advisers efficiently and cost effectively; and what happens after judgment.

European Medicines Agency produces Q&A document on impact of Brexit for MA holders

24 July 2017

As the UK prepares to leave the EU, the holders of marketing authorisations for human or veterinary centrally approved need to ensure that that they take appropriate steps to ensure that they comply with the establishment requirements in the EU/EEA.

UPC – UK moves forward whilst Germany stalls

13 July 2017

The Unified Patent Court (UPC) is intended to provide a regional forum resolve patent disputes. UPC decisions will have effect in all 25 states participating in the UPC, providing a single forum to resolve disputes.

Squeezed out of validity and into the jurisdiction

13 July 2017

UCB licensed Chugai rights to its tocilizumab patents. The licence contained an exclusive jurisdiction clause in favour of the English courts. Only one US patent remained in force. Chugai wanted a declaration that its tocilizumab products (sold only in the US) fell outside of the scope of the last patent and accordingly no royalty payments were due under the licence.

Sandoz & Hexal v Searle & Janssen Sciences Ireland: What is the formula for patent extensions?

13 July 2017

The UK High Court has held that a pharmaceutical product claimed only within a Markush formula and not expressly referred to in the patent was protected by the patent for the purposes of obtaining a Supplementary Protection Certificate (SPC).

Brands and IP newsnotes - issue 5

27 June 2017

Welcome to the 5th edition of our Brands & IP newsnotes put together to bring you the latest, and most interesting legal developments affecting intellectual property law. In this issue we cover; the potential pitfalls of social media, design by artificial intelligence, interesting trade mark applications and cases, an update on the UPC, and the importance of protecting trade secrets.

Back To Top